ORGAN DISTRIBUTION OF ERYTHROPOIETIN MESSENGER-RNA IN NORMAL AND UREMIC RATS

被引:98
作者
TAN, CC
ECKARDT, KU
RATCLIFFE, PJ
机构
[1] JOHN RADCLIFFE HOSP, INST MOLEC MED, NUFFIELD DEPT CLIN MED, OXFORD OX3 9DU, ENGLAND
[2] UNIV ZURICH, DEPT PHYSIOL, CH-8006 ZURICH, SWITZERLAND
基金
英国惠康基金;
关键词
D O I
10.1038/ki.1991.181
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We used RNAase protection assays to measure low levels of erythropoietin messenger RNA (EPO mRNA) in the organs of unstimulated rats, and to compare basal and stimulated levels of EPO mRNA in the kidneys and extrarenal organs of rats rendered uremic by subtotal nephrectomy, with pair-fed controls. Using this sensitive assay, EPO mRNA was measured in the kidneys of unstimulated control animals and was detectable, at lower levels, in the liver and lung. After exposure to hypoxia, there was a 150-fold increase in renal EPO mRNA. Hepatic EPO mRNA was also greatly increased and accounted for 39 +/- 10% of the total. The small quantity of EPO mRNA in lung did not increase, but EPO mRNA became detectable in spleen. Animals subjected to subtotal nephrectomy became uremic and anemic (hematocrit 0.32 +/- 0.04 vs. 0.43 +/- 0.04 in controls, P = 0.002), but serum EPO concentrations were not significantly increased (32 +/- 9 vs. 24 +/- 6 mU/ml, P = 0.14). However, after hypoxic exposure, uremic animals increased serum EPO concentrations greatly, although the response was less than in controls (349 +/- 82 vs. 1009 +/- 238 mU/ml, P = 0.002). After hypoxia, extrarenal EPO mRNA levels in uremic animals were similar to controls. In particular, the large hepatic potential for EPO mRNA synthesis was unchanged but accounted for a greater proportion (84 +/- 5%) of the total EPO mRNA. The renal EPO mRNA content was reduced, as expected, after subtotal nephrectomy, but increased 50-fold after hypoxia. In this model of chronic renal failure, despite anemia, a large potential for EPO synthesis exists in liver and remnant kidney.
引用
收藏
页码:69 / 76
页数:8
相关论文
共 28 条
  • [1] MULTIPLE SITE ESTIMATES OF ERYTHROPOIETIN AND RENIN IN POLYCYTHEMIC KIDNEY-TRANSPLANT PATIENTS
    AEBERHARD, JM
    SCHNEIDER, PA
    VALLOTTON, MB
    KURTZ, A
    LESKI, M
    [J]. TRANSPLANTATION, 1990, 50 (04) : 613 - 616
  • [2] EXPRESSION OF THE ERYTHROPOIETIN GENE
    BERU, N
    MCDONALD, J
    LACOMBE, C
    GOLDWASSER, E
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (07) : 2571 - 2575
  • [3] ANEMIA INDUCES ACCUMULATION OF ERYTHROPOIETIN MESSENGER-RNA IN THE KIDNEY AND LIVER
    BONDURANT, MC
    KOURY, MJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (07) : 2731 - 2733
  • [4] CARO J, 1979, J LAB CLIN MED, V93, P449
  • [5] RELATION OF SERUM ERYTHROPOIETIN LEVELS TO RENAL EXCRETORY FUNCTION - EVIDENCE FOR LOWERED SET POINT FOR ERYTHROPOIETIN PRODUCTION IN CHRONIC RENAL-FAILURE
    CHANDRA, M
    CLEMONS, GK
    MCVICAR, MI
    [J]. JOURNAL OF PEDIATRICS, 1988, 113 (06) : 1015 - 1021
  • [6] CLEMONS GK, 1987, EXP HEMATOL, V15, P18
  • [7] COTES PM, 1989, Q J MED, V70, P113
  • [8] EVALUATION OF THE STABILITY OF HUMAN ERYTHROPOIETIN IN SAMPLES FOR RADIOIMMUNOASSAY
    ECKARDT, KU
    KURTZ, A
    HIRTH, P
    SCIGALLA, P
    WIECZOREK, L
    BAUER, C
    [J]. KLINISCHE WOCHENSCHRIFT, 1988, 66 (06): : 241 - 245
  • [9] RATE OF ERYTHROPOIETIN FORMATION IN HUMANS IN RESPONSE TO ACUTE HYPOBARIC HYPOXIA
    ECKARDT, KU
    BOUTELLIER, U
    KURTZ, A
    SCHOPEN, M
    KOLLER, EA
    BAUER, C
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 1989, 66 (04) : 1785 - 1788
  • [10] CORRECTION OF THE ANEMIA OF END-STAGE RENAL-DISEASE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESULTS OF A COMBINED PHASE-I AND PHASE-II CLINICAL-TRIAL
    ESCHBACH, JW
    EGRIE, JC
    DOWNING, MR
    BROWNE, JK
    ADAMSON, JW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) : 73 - 78